Is it safe to use smoking cessation therapeutics during pregnancy?

Bibliography

• Aliyu MH, Lynch O, Wilson RE, et al. Association between tobacco use in pregnancy and placenta-associated syndromes: a population-based study. Arch Gynecol Obstet 2011;283(4):729-34
   PubMed Web of Science ®Google Scholar
• Pineles BL, Park E, Samet JM. Systematic review and meta-analysis of miscarriage and maternal exposure to tobacco smoke during pregnancy. Am J Epidemiol 2014;179(7):807-23
   PubMed Web of Science ®Google Scholar
• Zhang K, Wang X. Maternal smoking and increased risk of sudden infant death syndrome: a meta-analysis. Leg Med (Tokyo) 2013;15(3):115-21
   PubMed Web of Science ®Google Scholar
• Tong VT, Dietz PM, Morrow B, et al. Trends in smoking before, during, and after pregnancy–pregnancy risk assessment monitoring system, united states, 40 sites, 2000-2010. MMWR Surveill Summ 2013;62(6):1-19
   PubMed Web of Science ®Google Scholar
• Cui Y, Shooshtari S, Forget EL, et al. Smoking during pregnancy: findings from the. 2009-2010 Canadian Community Health Survey. PLoS One 2014;9(1):e84640
   PubMed Web of Science ®Google Scholar
• Jimenez Ruiz CA. Nicotine replacement therapy during pregnancy. Arch Bronconeumol 2006;42(8):404-9
   PubMed Web of Science ®Google Scholar
• Kaneita Y, Tomofumi S, Takemura S, et al. Prevalence of smoking and associated factors among pregnant women in Japan. Prev Med 2007;45(1):15-20
   PubMed Web of Science ®Google Scholar
• Mohsin M, Bauman AE. Socio-demographic factors associated with smoking and smoking cessation among 426,344 pregnant women in New South Wales. Australia. BMC Public Health 2005;5:138
   PubMed Web of Science ®Google Scholar
• Tappin DM, MacAskill S, Bauld L, et al. Smoking prevalence and smoking cessation services for pregnant women in Scotland. Substance Abuse Treat Prev Policy 2010;5:1
   PubMed Web of Science ®Google Scholar
• Ruggiero L, Tsoh JY, Everett K, et al. The transtheoretical model of smoking: comparison of pregnant and nonpregnant smokers. Addict Behav 2000;25(2):239-51
   PubMed Web of Science ®Google Scholar
• England LJ, Kendrick JS, Wilson HG, et al. Effects of smoking reduction during pregnancy on the birth weight of term infants. Am J Epidemiol 2001;154(8):694-701
   PubMed Web of Science ®Google Scholar
• Orton S, Bowker K, Cooper S, et al. Longitudinal cohort survey of women’s smoking behaviour and attitudes in pregnancy: study methods and baseline data. BMJ Open 2014;4(5):e004915
   Web of Science ®Google Scholar
• WHO. WHO recommendations for the prevention and management of tobacco use and second-hand smoke exposure in pregnancy. WHO Guidelines Approved by the Guidelines Review Committee, Geneva; 2013
   Google Scholar
• American college of obstetricians and gynecologists. Smoking cessation during pregnancy. Committee Opinion No. 471. Obstet Gynecol 2010.116:1241-4. Available from: www.acog.org/Resources_And_Publications/Committee_Opinions/Committee_on_Health_Care_for_Underserved_Women/Smoking_Cessation_During_Pregnancy [Last accessed 11 September 2014]
   Google Scholar
• PHS Guideline update panel liaisons, and staff. treating tobacco use and dependence: 2008 update U.S. Public health service clinical practice guideline executive summary. Respir Care 2008;53(9):1217-22
   PubMed Web of Science ®Google Scholar
• Chamberlain C, O’Mara-Eves A, Oliver S, et al. Psychosocial interventions for supporting women to stop smoking in pregnancy. Cochrane Database Syst Rev 2013;10:CD001055
   PubMed Web of Science ®Google Scholar
• Benowitz N, Dempsey D. Pharmacotherapy for smoking cessation during pregnancy. Nicotine Tob Res 2004;6(Suppl 2):S189-202
   PubMed Web of Science ®Google Scholar
• Okuyemi KS, Ahluwalia JS, Harris KJ. Pharmacotherapy of smoking cessation. Arch Fam Med 2000;9(3):270-81
   PubMedGoogle Scholar
• Ontario Medical Association. Rethinking stop-smoking medications: treatment myths and medical realities. [update 2008]. Ont Med Rev 2008;75(1):22-34
   Google Scholar
• Peters MJ, Morgan LC. The pharmacotherapy of smoking cessation. Med J Aust 2002;176(10):486-90
   PubMed Web of Science ®Google Scholar
• Raw M, Regan S, Rigotti NA, McNeill A. A survey of tobacco dependence treatment services in 36 countries. Addiction 2009;104(2):279-87
   PubMed Web of Science ®Google Scholar
• Aubin HJ, Luquiens A, Berlin I. Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice. Br J Clin Pharmacol 2014;77(2):324-36
   PubMed Web of Science ®Google Scholar
• Phelan S. Smoking cessation in pregnancy. Obstet Gynecol Clin North Am 2014;41(2):255-66
   PubMed Web of Science ®Google Scholar
• Coleman T, Chamberlain C, Davey MA, et al. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2012;9:CD010078
   PubMedGoogle Scholar
• Rustemeier K, Stabbert R, Haussmann HJ, et al. Evaluation of the potential effects of ingredients added to cigarettes. Part 2: chemical composition of mainstream smoke. Food Chem Toxicol 2002;40(1):93-104
   PubMed Web of Science ®Google Scholar
• Swauger JE, Steichen TJ, Murphy PA, Kinsler S. An analysis of the mainstream smoke chemistry of samples of the U.S. Cigarette market acquired between 1995 and 2000. Regul Toxicol Pharmacol 2002;35(2 Pt 1):142-56
   PubMed Web of Science ®Google Scholar
• Glynn DA, Cryan JF, Kent P, et al. Update on smoking cessation therapies Adv Ther 2009;26(4):369-82
   Google Scholar
• Dwoskin LP, Smith AM, Wooters TE, et al. Nicotinic receptor-based therapeutics and candidates for smoking cessation. Biochem Pharmacol 2009;78(7):732-43
   PubMed Web of Science ®Google Scholar
• Luck W, Nau H, Hansen R, Steldinger R. Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers. Dev Pharmacol Ther 1985;8(6):384-95
   PubMedGoogle Scholar
• Luck W, Nau H. Nicotine and cotinine concentrations in the milk of smoking mothers: influence of cigarette consumption and diurnal variation. Eur J Pediatr 1987;146(1):21-6
   PubMed Web of Science ®Google Scholar
• Bruin JE, Gerstein HC, Holloway AC. Long-term consequences of fetal and neonatal nicotine exposure: a critical review. Toxicol Sci 2010;116(2):364-74
   PubMed Web of Science ®Google Scholar
• Ginzel KH, Maritz GS, Marks DF, et al. Critical review: nicotine for the fetus, the infant and the adolescent? J Health Psychol 2007;12(2):215-24
   PubMed Web of Science ®Google Scholar
• Slotkin TA. If nicotine is a developmental neurotoxicant in animal studies, dare we recommend nicotine replacement therapy in pregnant women and adolescents? Neurotoxicol Teratol 2008;30(1):1-19
   PubMed Web of Science ®Google Scholar
• Wang D, Connock M, Barton P, et al. ‘Cut down to quit’ with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis. Health Technol Assess 2008;12(2): iii-iv ix-xi 1-135
   Web of Science ®Google Scholar
• Coleman T, Chamberlain C, Cooper S, Leonardi-Bee J. Efficacy and safety of nicotine replacement therapy for smoking cessation in pregnancy: Systematic review and meta-analysis. Addiction 2011;106(1):52-61
   PubMed Web of Science ®Google Scholar
• Wisborg K, Henriksen TB, Jespersen LB, Secher NJ. Nicotine patches for pregnant smokers: a randomized controlled study. Obstet Gynecol 2000;96(6):967-71
   PubMed Web of Science ®Google Scholar
• Berlin I, Grange G, Jacob N, Tanguy ML. Nicotine patches in pregnant smokers: randomised, placebo controlled, multicentre trial of efficacy. BMJ 2014;348:g1622
   PubMed Web of Science ®Google Scholar
• Hotham ED, Gilbert AL, Atkinson ER. A randomised-controlled pilot study using nicotine patches with pregnant women. Addict Behav 2006;31(4):641-8
   PubMed Web of Science ®Google Scholar
• Pollak KI, Oncken CA, Lipkus IM, et al. Nicotine replacement and behavioral therapy for smoking cessation in pregnancy. Am J Prev Med 2007;33(4):297-305
   PubMed Web of Science ®Google Scholar
• Coleman T, Cooper S, Thornton JG, et al. A randomized trial of nicotine-replacement therapy patches in pregnancy. N Engl J Med 2012;366(9):808-18
   PubMed Web of Science ®Google Scholar
• Oncken C, Dornelas E, Greene J, et al. Nicotine gum for pregnant smokers: a randomized controlled trial. Obstet Gynecol 2008;112(4):859-67
   PubMed Web of Science ®Google Scholar
• Bowker KA, Lewis S, Coleman T, et al. Comparison of cotinine levels in pregnant women while smoking and when using nicotine replacement therapy. Nicotine Tob Res 2014;16(6):895-8
   PubMed Web of Science ®Google Scholar
• Brose LS, McEwen A, West R. Association between nicotine replacement therapy use in pregnancy and smoking cessation. Drug Alcohol Depend 2013;132(3):660-4
   PubMed Web of Science ®Google Scholar
• von Kries R, Toschke AM, Koletzko B, Slikker WMaternal smoking during pregnancy and childhood obesity. Am J Epidemiol 2002;156(10):954-61
   PubMed Web of Science ®Google Scholar
• CAN-ADAPTT. Canadian smoking cessation clinical practice guideline. canadian action network for the advancement, dissemination and adoption of practice-informed tobacco treatment, centre for addiction and mental health. Toronto, Canada; 2011. Available from: informahealthcare.com/userimages/ContentEditor/1232541144107/Guidelines_EODC.pdf [Last accessed 11 September 2014]
   Google Scholar
• Ministry of Health. New Zealand Smoking Cessation Guidelines. Ministry of Health, Wellington, New Zealand. 2007. Available from: www.treatobacco.net/en/uploads/documents/Treatment%20Guidelines/New%20Zealand%20treatment%20guidelines%20in%20English%202007.pdf [Last accessed 11 September 2014]
   Google Scholar
• ASAM. Utilisation des traitements de substitution nicotinique (TSN) chez les femmes enceintes – Point dèinformationépoint dètape. Agence nationale de sècuritè du medicament et des produits de santé. 2007. Available from: http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Utilisation-des-traitements-de-substitution-nicotinique-TSN-chez-les-femmes-enceintes-Point-d-information-point-d-etape [Last accessed 11 September 2014]
   Google Scholar
• NICE. Quitting smoking during pregnancy and following childbirth. National Institute for Health and Care Excellence. 2010. Available from: www.nice.org.uk/guidance/ph26/chapter/recommendations#recommendation-5-use-ofnrt-and-other-pharmacological-support [Last accessed 11 September 2014]
   Google Scholar
• Merritt T, Mazela J, Merritt A. Tobacco smoking and its consequences on reproductive health: the impact of a lifestyle choices including cigarette smoke exposure on fertility and birth defects. Przegl Lek 2013;70(10):779-83
   PubMedGoogle Scholar
• Koch S, Vilser C, Gross W, Schleussner E. [smoking during pregnancy: Risk for intrauterine growth retardation and persisting microsomia]. Z Geburtshilfe Neonatol 2012;216(2):77-81
   PubMedGoogle Scholar
• Forinash AB, Pitlick JM, Clark K, Alstat V. Nicotine replacement therapy effect on pregnancy outcomes. Ann Pharmacother 2010;44(11):1817-21
   PubMed Web of Science ®Google Scholar
• Milidou I, Henriksen TB, Jensen MS, et al. Nicotine replacement therapy during pregnancy and infantile colic in the offspring. Pediatrics 2012;129(3):e652-8
   PubMed Web of Science ®Google Scholar
• Lassen TH, Madsen M, Skovgaard LT. Maternal use of nicotine replacement therapy during pregnancy and offspring birth weight: a study within the Danish National Birth Cohort. Paediatr Perinat Epidemiol 2010;24(3):272-81
   PubMed Web of Science ®Google Scholar
• Ma N, Nicholson CJ, Wong M, et al. Fetal and neonatal exposure to nicotine leads to augmented hepatic and circulating triglycerides in adult male offspring due to increased expression of fatty acid synthase. Toxicol Appl Pharmacol 2014;275(1):1-11
   PubMed Web of Science ®Google Scholar
• Schneider T, Ilott N, Brolese G, et al. Prenatal exposure to nicotine impairs performance of the 5-choice serial reaction time task in adult rats. Neuropsychopharmacology 2011;36(5):1114-25
   PubMed Web of Science ®Google Scholar
• Behl M, Rao D, Aagaard K, et al. Evaluation of the association between maternal smoking, childhood obesity, and metabolic disorders: a national toxicology program workshop review. Environ Health Perspect 2013;121(2):170-80
   PubMed Web of Science ®Google Scholar
• Duijts L. Fetal and infant origins of asthma. Eur J Epidemiol 2012;27(1):5-14
   PubMed Web of Science ®Google Scholar
• Harding R, Maritz G. Maternal and fetal origins of lung disease in adulthood. Semin Fetal Neonatal Med 2012;17(2):67-72
   PubMed Web of Science ®Google Scholar
• Petre MA, Petrik J, Ellis R, et al. Fetal and neonatal exposure to nicotine disrupts postnatal lung development in rats: role of VEGF and its receptors. Int J Toxicol 2011;30(2):244-52
   PubMed Web of Science ®Google Scholar
• Shi W, Bellusci S, Warburton D. Lung development and adult lung diseases. Chest 2007;132(2):651-6
   PubMed Web of Science ®Google Scholar
• Sekhon HS, Jia Y, Raab R, et al. Prenatal nicotine increases pulmonary alpha7 nicotinic receptor expression and alters fetal lung development in monkeys. J Clin Invest 1999;103(5):637-47
   PubMed Web of Science ®Google Scholar
• Sekhon HS, Proskocil BJ, Clark JA, Spindel ER. Prenatal nicotine exposure increases connective tissue expression in foetal monkey pulmonary vessels. Eur Respir J 2004;23(6):906-15
   PubMed Web of Science ®Google Scholar
• Wongtrakool C, Wang N, Hyde DM, et al. Prenatal nicotine exposure alters lung function and airway geometry through alpha7 nicotinic receptors. Am J Respir Cell Mol Biol 2012;46(5):695-702
   PubMed Web of Science ®Google Scholar
• Wongtrakool C, Grooms K, Ping XD, et al. In utero nicotine exposure promotes m2 activation in neonatal mouse alveolar macrophages. Pediatr Res 2012;72(2):147-53
   PubMed Web of Science ®Google Scholar
• Gratchev A, Guillot P, Hakiy N, et al. Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaig-h3. Scand J Immunol 2001;53(4):386-92
   PubMed Web of Science ®Google Scholar
• Sekhon HS, Keller JA, Benowitz NL, et al. Prenatal nicotine exposure alters pulmonary function in newborn rhesus monkeys. Am J Respir Crit Care Med 2001;164:989-94
   PubMed Web of Science ®Google Scholar
• Rehan VK, Asotra K, Torday JS. The effects of smoking on the developing lung: insights from a biologic model for lung development, homeostasis, and repair. Lung 2009;187:281-9
   PubMed Web of Science ®Google Scholar
• Dasgupta C, Xiao D, Xu Z, et al. Developmental nicotine exposure results in programming of alveolar simplification and interstitial pulmonary fibrosis in adult male rats. Reprod Toxicol 2012;34:370-7
   PubMed Web of Science ®Google Scholar
• Rehan VK, Liu J, Naeem E, et al. Perinatal nicotine exposure induces asthma in second generation offspring. BMC Med 2012;10:129
   PubMed Web of Science ®Google Scholar
• Cooper S, Taggar J, Lewis S, et al. Effect of nicotine patches in pregnancy on infant and maternal outcomes at 2 years: follow-up from the randomised, double-blind, placebo-controlled snap trial. Lancet Respir Med 2014;2:728-37
   PubMed Web of Science ®Google Scholar
• Cnattingius S. The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob Res 2004;6:S125-40
   PubMed Web of Science ®Google Scholar
• Thiering E, Bruske I, Kratzsch J, et al. Prenatal and postnatal tobacco smoke exposure and development of insulin resistance in 10 year old children. Int J Hyg Environ Health 2011;214:361-8
   PubMed Web of Science ®Google Scholar
• Weng SF, Redsell SA, Swift JA, et al. Systematic review and meta-analyses of risk factors for childhood overweight identifiable during infancy. Arch Dis Child 2012;97:1019-26
   PubMed Web of Science ®Google Scholar
• Bruin JE, Kellenberger LD, Gerstein HC, et al. Fetal and neonatal nicotine exposure and postnatal glucose homeostasis: identifying critical windows of exposure. J Endocrinol 2007;194:171-8
   PubMed Web of Science ®Google Scholar
• Lim R, Sobey CG. Maternal nicotine exposure and fetal programming of vascular oxidative stress in adult offspring. Br J Pharmacol 2011;164:1397-9
   PubMed Web of Science ®Google Scholar
• Xiao D, Huang X, Yang S, et al. Estrogen normalizes perinatal nicotine-induced hypertensive responses in adult female rat offspring. Hypertension 2013;61:1246-54
   PubMed Web of Science ®Google Scholar
• Ernst M, Moolchan ET, Robinson ML. Behavioral and neural consequences of prenatal exposure to nicotine. J Am Acad Child Adolesc Psychiatry 2001;40:630-41
   PubMed Web of Science ®Google Scholar
• DiFranza JR, Aligne CA, Weitzman M. Prenatal and postnatal environmental tobacco smoke exposure and children’s health. Pediatrics 2004;113:1007-15
   PubMed Web of Science ®Google Scholar
• Zhu JL, Olsen J, Liew Z, et al. Parental smoking during pregnancy and ADHD in children: the Danish national birth cohort. Pediatrics 2014;134:e382-8
   PubMed Web of Science ®Google Scholar
• Sengupta SM, Fortier ME, Thakur GA, et al. Parental psychopathology in families of children with attention-deficit/hyperactivity disorder and exposed to maternal smoking during pregnancy. J Child Psychol Psychiatry 2014; doi: 10.1111/jcpp.12286
   PubMedGoogle Scholar
• Holz NE, Boecker R, Baumeister S, et al. Effect of prenatal exposure to tobacco smoke on inhibitory control: neuroimaging results from a 25-year prospective study. JAMA Psychiatry 2014;71:786-96
   PubMed Web of Science ®Google Scholar
• Parameshwaran K, Buabeid MA, Karuppagounder SS, et al. Developmental nicotine exposure induced alterations in behavior and glutamate receptor function in hippocampus. Cell Mol Life Sci 2012;69:829-41
   PubMed Web of Science ®Google Scholar
• Schneider T, Bizarro L, Asherson PJ, et al. Hyperactivity, increased nicotine consumption and impaired performance in the five-choice serial reaction time task in adolescent rats prenatally exposed to nicotine. Psychopharmacology (Berl) 2012;223:401-15
   PubMed Web of Science ®Google Scholar
• Eppolito AK, Bachus SE, McDonald CG, et al. Late emerging effects of prenatal and early postnatal nicotine exposure on the cholinergic system and anxiety-like behavior. Neurotoxicol Teratol 2010;32:336-45
   PubMed Web of Science ®Google Scholar
• Zhu J, Zhang X, Xu Y, et al. Prenatal nicotine exposure mouse model showing hyperactivity, reduced cingulate cortex volume, reduced dopamine turnover, and responsiveness to oral methylphenidate treatment. J Neurosci 2012;32:9410-18
   PubMed Web of Science ®Google Scholar
• Dwyer JB, McQuown SC, Leslie FM. The dynamic effects of nicotine on the developing brain. Pharmacol Ther 2009;122:125-39
   PubMed Web of Science ®Google Scholar
• Buka SL, Shenassa ED, Niaura R. Elevated risk of tobacco dependence among offspring of mothers who smoked during pregnancy: a 30-year prospective study. Am J Psychiatry 2003;160:1978-84
   PubMed Web of Science ®Google Scholar
• Cornelius MD, Leech SL, Goldschmidt L, et al. Prenatal tobacco exposure: is it a risk factor for early tobacco experimentation? Nicotine Tob Res 2000;2:45-52
   PubMedGoogle Scholar
• Stroud LR, Papandonatos GD, Shenassa E, et al. Prenatal glucocorticoids and maternal smoking during pregnancy independently program adult nicotine dependence in daughters: a 40-year prospective study. Biol Psychiatry 2013;75:47-55
   PubMed Web of Science ®Google Scholar
• Mantella NM, Kent PF, Youngentob SL. Fetal nicotine exposure increases preference for nicotine odor in early postnatal and adolescent, but not adult. rats. PLoS One 2013;8:e84989
   Web of Science ®Google Scholar
• Mizrak S, Turan V, Terek MC, et al. The effect of long term nicotine exposure on nicotine addiction and fetal growth. J Turk Ger Gynecol Assoc 2012;13:237-41
   Google Scholar
• Liu L, Liu F, Kou H, et al. Prenatal nicotine exposure induced a hypothalamic-pituitary-adrenal axis-associated neuroendocrine metabolic programmed alteration in intrauterine growth retardation offspring rats. Toxicol Lett 2012;214:307-13
   PubMed Web of Science ®Google Scholar
• Harrod SB, Lacy RT, Morgan AJ. Offspring of prenatal IV nicotine exposure exhibit increased sensitivity to the reinforcing effects of methamphetamine. Front Pharmacol 2012;3:116
   Google Scholar
• Franke RM, Park M, Belluzzi JD, et al. Prenatal nicotine exposure changes natural and drug-induced reinforcement in adolescent male rats. Eur J Neurosci 2008;27:2952-61
   PubMed Web of Science ®Google Scholar
• Hiscock R, Goniewicz ML, McEwen A, et al. E-cigarettes: online survey of UK smoking cessation practitioners. Tob Induc Dis 2014;12:13
   PubMed Web of Science ®Google Scholar
• Bertholon JF, Becquemin MH, Annesi-Maesano I, et al. Electronic cigarettes: a short review. Respiration 2013;86:433-8
   PubMed Web of Science ®Google Scholar
• Burstyn I. Peering through the mist: systematic review of what the chemistry of contaminants in electronic cigarettes tells us about health risks. BMC Public Health 2014;14:18
   PubMed Web of Science ®Google Scholar
• Schober W, Szendrei K, Matzen W, et al. Use of electronic cigarettes (e-cigarettes) impairs indoor air quality and increases FeNO levels of e-cigarette consumers. Int J Hyg Environ Health 2014;217:628-37
   PubMed Web of Science ®Google Scholar
• Orr KK, Asal NJ. Efficacy of electronic cigarettes for smoking cessation. Ann Pharmacother 2014;48(11):1502-06
   PubMed Web of Science ®Google Scholar
• Dawkins L, Corcoran O. Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology (Berl) 2014;231:401-7
   PubMed Web of Science ®Google Scholar
• Etter JF, Bullen C. Saliva cotinine levels in users of electronic cigarettes. Eur Respir J 2011;38:1219-20
   PubMed Web of Science ®Google Scholar
• Vansickel AR, Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob Res 2013;15:267-70
   PubMed Web of Science ®Google Scholar
• Electronic nicotine delivery systems. WHO framework convention on tobacco control. Moscow, Russia: conference of the parties to the WHO framework convention on tobacco control. 2014. Available from: http://apps.who.int/gb/fctc/PDF/cop6/FCTC_COP6_10-en.pdf [Last accessed 11 September 2014]
   Google Scholar
• Zhu SH, Gamst A, Lee M, et al. The use and perception of electronic cigarettes and snus among the U.S. population. PLoS One 2013;8:e79332
   PubMed Web of Science ®Google Scholar
• Odum LE, O’Dell KA, Schepers JS. Electronic cigarettes: do they have a role in smoking cessation? J Pharm Pract 2012;25:611-14
   PubMedGoogle Scholar
• Mihalak KB, Carroll FI, Luetje CW. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol 2006;70:801-5
   PubMed Web of Science ®Google Scholar
• Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2012;4:CD006103
   PubMedGoogle Scholar
• Xi ZX. Preclinical pharmacology, efficacy and safety of varenicline in smoking cessation and clinical utility in high risk patients. Drug Healthc Patient Saf 2010;2010:39-48
   Google Scholar
• Le Houezec J, Aubin HJ. Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence. Expert Opin Pharmacother 2013;14:1959-67
   PubMed Web of Science ®Google Scholar
• Champix (varenicline tartrate tablets): Pfizer Canada Inc. Pfizer, Quebec, Canada 2014. Available from: www.pfizer.ca/en/our_products/products/monograph/152 [Last accessed 11 September 2014]
   Google Scholar
• NICE: how to stop smoking in pregnancy and following childbirth. National Institute for Health and Clinical Excellence. National Institute for Health and Clinical Excellence, London, UK; 2010. Available from: www.nice.org.uk/guidance/ph26 [Last accessed 11 September 2014]
   Google Scholar
• Treating tobacco use and dependence: 2008 update. Tobacco use and dependence guideline panel. US department of health and human services; Rockville, MD: 2008. Available from: www.ncbi.nlm.nih.gov/books/NBK63952/ [Last accessed 11 September 2014]
   Google Scholar
• Myung SK, Ju W, Jung HS, et al. Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta-analysis. BJOG 2012;119:1029-39
   PubMed Web of Science ®Google Scholar
• Harrison-Woolrych M, Paterson H, Tan M. Exposure to the smoking cessation medicine varenicline during pregnancy: a prospective nationwide cohort study. Pharmacoepidemiol Drug Saf 2013;22:1086-92
   PubMed Web of Science ®Google Scholar
• Wellbutrin label and approval history; U.S. food and drug administration center for drug evaluation and research. FDA/U.S. Department of Health & Human Service, Silver Spring, MD; 2007. Available from: www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021928_s000_Chantix_PharmR.pdf [Last accessed 11 September 2014]
   Google Scholar
• Kaplan YC, Olgac Dundar N, Kasap B, et al. Pregnancy outcome after varenicline exposure in the first trimester. Case Rep Obstet Gynecol 2014;2014:263981
   Google Scholar
• Zyban (bupropion hydrochloride) sustained-release tablets, for oral use. GlaxoSmithKline,,Research Triangle Park, NC: 2014. Available from: www.gsksource.com/gskprm/htdocs/documents/ZYBAN-PI-MG.PDF [Last accessed 11 September 2014]
   Google Scholar
• Slemmer JE, Martin BR, Damaj MI. Bupropion is a nicotinic antagonist. J Pharmacol Exp Ther 2000;295:321-7
   PubMed Web of Science ®Google Scholar
• Rigotti NA, Park ER, Chang Y, et al. Smoking cessation medication use among pregnant and postpartum smokers. Obstet Gynecol 2008;111:348-55
   PubMed Web of Science ®Google Scholar
• Louik C, Kerr S, Mitchell AA. First-trimester exposure to bupropion and risk of cardiac malformations. Pharmacoepidemiol Drug Saf 2014; doi: 10.1002/pds.3661
   PubMed Web of Science ®Google Scholar
• Andrade SE, Raebel MA, Brown J, et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008;198:e191-5
   PubMed Web of Science ®Google Scholar
• Alwan S, Reefhuis J, Rasmussen SA, et al. Patterns of antidepressant medication use among pregnant women in a united states population. J Clin Pharmacol 2011;51:264-70
   PubMed Web of Science ®Google Scholar
• Chan B, Einarson A, Koren G. Effectiveness of bupropion for smoking cessation during pregnancy. J Addict Dis 2005;24:19-23
   PubMed Web of Science ®Google Scholar
• Chun-Fai-Chan B, Koren G, Fayez I, et al. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol 2005;192:932-6
   PubMed Web of Science ®Google Scholar
• Cole JA, Modell JG, Haight BR, et al. Bupropion in pregnancy and the prevalence of congenital malformations. Pharmacoepidemiol Drug Saf 2007;16:474-84
   PubMed Web of Science ®Google Scholar
• Einarson A, Choi J, Einarson TR, et al. Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study. Can J Psychiatry 2009;54:242-6
   PubMed Web of Science ®Google Scholar
• Alwan S, Reefhuis J, Botto LD, et al. Maternal use of bupropion and risk for congenital heart defects. Am J Obstet Gynecol 2010;203:52-e51-6
   PubMed Web of Science ®Google Scholar
• De Long N, Hyslop JR, Nicholson CJ, et al. Postnatal metabolic and reproductive consequences of fetal and neonatal exposure to the smoking cessation drug bupropion. Reprod Sci 2013;20:1156-61
   PubMed Web of Science ®Google Scholar
• Reis M, Kallen B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med 2010;40:1723-33
   PubMed Web of Science ®Google Scholar
• Reynolds LP, Caton JS, Redmer DA, et al. Evidence for altered placental blood flow and vascularity in compromised pregnancies. J Physiol 2006;572:51-8
   PubMed Web of Science ®Google Scholar